Investing.com – Lifecore Biomedical Co. (NASDAQ: ) Q1 reports missed analyst expectations. with revenue higher than expected numbers According to information published on Thursday.
Lifecore Biomedical’s earnings per share (EPS) were $-1.19 on revenue of $31.55M. Investing.com previously viewed the figure at $-0.45 per share on a $29.05M earnings basis.
Lifecore Biomedical’s shares were down 6.28% to $8.50 during the day after the earnings news.
In addition to Lifecore Biomedical, there are other companies. in the healthcare sector of the NASDAQ stock market who reported earnings during this month
Eli Lilly previously reported second-quarter earnings of $2.11 per share on revenue of $8.31B, compared with expectations of $1.98 and revenue of $7.58B.
While Novo Nordisk ADR’s recent results were in line with analysts’ forecasts, the performance of the Novo Nordisk ADR is expected to continue. Second-quarter profit was $1.28 per share and revenue was $8.03B, compared with analysts’ expectations. Investing.com It expects earnings per share to be around $1.28 on a $8.21B revenue basis.
Stay up-to-date on company profits through Investing.com earnings calendar
2023-08-31 14:42:16
#Lifecore #Biomedical #Beats #Estimates #Earnings #Revenue #Beats #Estimates #Investing.com
